# To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.

> **NCT00141375** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 132 (—)

## Conditions studied

- Neuropathic Pain

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00141375
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 132 (—)
- **Last updated:** 2008-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00141375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00141375, "To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00141375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*